Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company’s ...

99% of patients were eligible for aspirin, per ACOG guidelines. Prescribing rates increased 81% after the intervention. Universal low-dose aspirin may particularly benefit lower-income urban ...